[1]
2017. Early biomarker response and patient preferences to oral and intramuscular vitamin B12 substitution in primary care: a randomised parallel-group trial. Swiss Medical Weekly. 147, 1314 (Apr. 2017), w14421. DOI:https://doi.org/10.4414/smw.2017.14421.